Interpace Biosciences, Inc.
Interpace Biosciences, Inc. (OTC: IDXG) is trading at $4.50, about ₹421 at today's USD/INR rate, as of 19 Nov 2026, 2:16 PM ET, down 17.13% today. Interpace Biosciences is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
$4.50
Today's high
$5.39
52 week low
$0.83
52 week high
$12.00
IDXG opened at $5.39, closed previously at $5.43, and has traded between $0.83 and $12.00 over the past 52 weeks.
About
Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation panel designed to identify malignant thyroid nodules. Additionally, ThyraMIR evaluates thyroid nodules for malignancy risk through the application of its proprietary microRNA gene-expression assay. Furthermore, RespriDx is a genomic diagnostic tool that aids clinicians in distinguishing between metastatic and recurrent lung cancer. Interpace Biosciences further supports the pharmaceutical and biotechnology sectors with services including pharmacogenomics testing, genotyping, biorepository solutions, and various custom scientific offerings. Its clientele primarily consists of physicians, hospitals, and clinics. Previously operating as Interpace Diagnostics Group, Inc., the company adopted its current name, Interpace Biosciences, Inc., in November 2019. Founded in 1986, its corporate headquarters are located in Parsippany, New Jersey.
Key statistics
Avg. volume
2.87K
Market cap
$26.56M
P/E Ratio
0.18
Price-to-sales ratio
0.70
Enterprise value
$4.12M
Free cash flow yield
100.62%
Debt-to-equity ratio
0.02
Return on equity
109.89%
ROIC
14.00%
Beta
0.64
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$38.73M
Earnings per share
$27.75
Free cash flow
$5.47M
Net profit margin
58.07%
Gross margin
65.63%
EBITDA
$4.76M
Revenue growth
-17.47%
Similar securities
This is not an investment recommendation
Interpace Biosciences for Indian investors
Interpace Biosciences is listed on OTC Markets. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Interpace Biosciences for Indian residents
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneInterpace Biosciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Interpace Biosciences on Paasa?
Interpace Biosciences (IDXG) has been listed on OTC Markets since 1998, in the Medical - Diagnostics & Research industry. Interpace Biosciences is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Interpace Biosciences share cost in rupees?
One Interpace Biosciences share is $4.50 — about ₹421 at a USD/INR rate of 93.51 on 18 Nov 2026. Both the Interpace Biosciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Interpace Biosciences shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Interpace Biosciences price.
Does Interpace Biosciences pay a dividend?
No. Interpace Biosciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does OTC trade, in Indian time?
OTC Markets trades 8:00 pm – 2:30 am IST in Indian time, so the close lands after midnight. The window shifts to 7:00 pm – 1:30 am IST when the US is on daylight time.
Do I have to declare Interpace Biosciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Interpace Biosciences?
Yes. Interpace Biosciences is priced in USD, so your rupee outcome combines the USD move with the USD/INR move between the day you remit and the day you convert back.